Studies using orotic acid for improving the controlled development of myocardial hypertrophy.
D000818:Animals; D006332:Cardiomegaly / Q000188:drug therapy* / Q000378:metabolism / Q000503:physiopathology; D004734:Energy Metabolism; D006003:Glycogen / Q000378:metabolism; D007930:Leucine / Q000378:metabolism; D008297:Male; D009200:Myocardial Contraction; D009206:Myocardium / Q000378:metabolism; D009963:Orotic Acid / Q000627:therapeutic use*; D014176:Protein Biosynthesis; D051381:Rats; D014498:Uracil / Q000627:therapeutic use; D014529:Uridine / Q000627:therapeutic use
D014498:Uracil; D009963:Orotic Acid; D006003:Glycogen; D007930:Leucine; D014529:Uridine